Sparsentan
Drug timelines are a Plus or Pro feature.
8 regulatory and trial events tracked for Sparsentan, covering 2021-07-27 to 2026-02-27. Get the full timeline:
Most recent: Clinical Trial Update: Sparsentan in Posttransplant Immunoglobulin A Nephropathy or Focal Segmental Glomerulosclerosis [Phase 4]